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ABSTRACT
There is growing interest on the potential relationship between hospital volume 
(HV) and outcomes as it might justify the centralization of care for rectal cancer 
surgery.
From the National Italian Hospital Discharge Dataset, data on 75,280 rectal 
cancer patients who underwent elective major surgery between 2002 and 2014 were 
retrieved and analyzed. HV was grouped into tertiles: low-volume performed 1-12, 
while high-volume hospitals performed 33+ procedures/year. The impact of HV on 
in-hospital mortality, abdominoperineal resection (APR), 30-day readmission, and 
length of stay (LOS) was assessed. Risk factors were calculated using multivariate 
logistic regression.
The proportion of procedures performed in low-volume hospitals decreased by 
6.7 percent (p<0.001). The rate of in-hospital mortality, APR and 30-day readmission 
was 1.3%, 16.3%, and 7.2%, respectively, and the median LOS was 13 days. The 
adjusted risk of in-hospital mortality (OR = 1.49, 95% CI = 1.25-1.78), APR (OR 1.10, 
95%CI 1.02-1.19), 30-day readmission (OR 1.49, 95%CI 1.38-1.61), and prolonged 
LOS (OR 2.29, 95%CI 2.05-2.55) were greater for low-volume hospitals than for 
high-volume hospitals.
This study shows an independent impact of HV procedures on all short-term 
outcome measures, justifying a policy of centralization for rectal cancer surgery, a 
process which is underway.
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INTRODUCTION
Rectal cancer requires complex surgical procedures 
and a multidisciplinary approach particularly when the 
tumor is located in the mid-low rectum and is locally 
advanced. Such complexity makes the management of 
this tumor similar to other cancers for which a significant 
association between hospital volume (HV) and outcomes 
has been found and centralization has been suggested 
[1, 2]). Actually, previous positive experiences in some 
European countries [3–5] seem to support this process. 
However, such centralization is source of debate and 
robust evidence of the relationship between HV procedures 
and outcomes has not been clearly demonstrated yet. As 
randomized trials are not feasible on this topic, current 
evidence is mainly based on retrospective observational 
studies. Differences in data source, study design, patient 
selection, HV definition, and healthcare systems make 
the findings of published studies widely heterogeneous, 
even among systematic reviews and meta-analyses [6–
9]. Moreover, some of the events (e.g., postoperative 
mortality) used to define an HV-outcome relationship 
occur rarely after rectal surgery. As a consequence, 
most studies are underpowered to capture statistically 
significant differences in postoperative mortality between 
low and high-volume hospitals. Further potential biases 
of previous studies derive from the use of either a single 
outcome or outcomes that are difficult to retrieve because 
they are underreported or omitted. Among the measures 
used to evaluate the relationship between HV and short-
term outcomes, the postoperative mortality and morbidity, 
the rate of abdominoperineal resection (APR), the length 
of stay (LOS) and the rate of unplanned readmission are 
the most used in the medical literature.
Given the unfeasibility of prospective randomized 
trial, we hypothesize that studies taking into account 
multiple outcome measures may strongly contribute 
to the debate of centralization of rectal cancer surgery. 
The strengths of these studies should be the longitudinal 
observational design and the easily retrieved data from 
large population-based datasets.
In this setting, we aimed to investigate whether 
short-term outcome measures are associated with HV after 
elective major rectal cancer procedures.
RESULTS
Baseline patient characteristics by hospital 
volume
During the study period, 75,280 patients met the 
inclusion criteria. (Figure 1) Low-volume hospitals 
performed 1-12, medium-volume 13-31, and high-
volume 32+ procedures per year. Compared with patients 
admitted to the high-volume, those admitted to the low-
volume hospitals were more likely to be older (p<0.001) 
male (p=0.018), have a worse Charlson score (p<0.001), 
have received rectal surgery in the first period of the 
study (p<0.001), have a higher rate of stoma creation 
(p<0.001), and be treated with an open approach 
(p<0.001). Conversely, they were less likely to have 
been hospitalized in the year prior to the index surgery 
(p<0.001). (Table 1)
Outcomes by hospital volume
In-hospital mortality
Among the entire cohort, the overall rate of in-
hospital mortality was 1.3%, ranging from 0.9% to 1.6% 
in high- and low-volume hospitals, respectively (p<0.001). 
(Table 2)
In the multivariate analysis, all the variables 
considered showed an independent impact on the in-
hospital mortality (Table 3). Compared with high volume 
hospitals, the adjusted OR of in-hospital mortality was 
49% higher in low-volume hospitals. (Table 3)
Abdominoperineal resection
Among the entire cohort, the overall rate of APR 
was 16.4%, ranging from 14.1% to 19.4% in high- and 
low-volume hospitals, respectively (p<0.001). (Table 2)
All the explicative variables except gender 
were independently associated with the APR rate. The 
probability of undergoing an APR was 49% higher in 
patients operated on in low-volume hospitals, as compared 
to high-volume hospitals. (Table 3)
Length of stay
Overall, the median (Interquartile Range) LOS was 
13 (10-19) days. It was ≥13 days in 39.4% and in 57.5% 
of cases in high- and low-volume hospitals, respectively 
(p=0.001). (Table 2)
With the exclusion of the abdominal surgery 
performed in the 3 years prior to the index surgery, the 
remaining variables were independently associated with 
the LOS. (Table 3)
Thirty-day readmission
Overall, the rate of 30-day readmission was 7.1%, 
ranging from 6.8% to 7.3% in the high- and low-volume 
hospitals, respectively (p=0.001). (Table 2)
Compared with high-volume hospitals, the adjusted 
OR of 30-day readmission was 10% higher in low-volume 
hospitals.
The HV, along with age, gender, hospitalization in 
the year prior to the index surgery, Charlson score, and 
study period was independently associated with high rates 
of 30-day readmission (Table 3).
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Variation of hospital volume and outcomes 
during the study period
Across the study period, both the proportion of 
patients who underwent surgery in low-volume hospitals 
and the proportion of hospitals that performed less than 
13 procedures/year decreased, indicating an ongoing and 
“spontaneous” process of centralization of rectal surgery. 
(Figure 2) In detail, the proportion of patients treated in 
low-volume hospitals decreased by 6.7 percent, from 
37.5% in 2002-2006 to 30.8% in 2011-2014, while the 
proportion of low-volume hospitals decreased by 6.4 
percent, from 81.8% in 2002-2006 to 75.4% in 2011-2014.
The proportion of patients with stoma creation 
during index hospitalization significantly increased during 
the study period: 31.5% in 2002-2006, 36.1% in 2007-
2010 and 41.8% in 2011-2014 (p<0.001).
Among the four outcome measures considered, 
the rates of the in-hospital mortality, APR, and the LOS 
decreased overtime, while the rate of 30-day readmission 
increased. This trend was similar for each HV category. 
(Figure 3)
DISCUSSION
The principal aim of this study was to investigate the 
association between HV and some of the most used short-
term outcomes after major elective rectal cancer surgery. 
APR resection was included in the outcomes as it is widely 
considered to reflect the ability of the surgeon to preserve 
the anal sphincters and, like postoperative mortality, has 
been suggested to be one of top scored colorectal cancer 
care quality measures [10].
Figure 1: Flow chart of patients’ selection.
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Table 1: Characteristics of patients and surgical approach by hospital volume
All patients   
Low volume
(1 - 12)
 
 
Medium 
volume
(13 - 31)
 
 
High 
volume
(32+)
 
 
n column % n column % n column % n column % p-value
No. of 
Patients 75,280 100.0 25,576 100.0 24,213 100.0 25,491 100.0
No. of 
hospitals/
year
8,280 100.0 6,534 100.0 1,283 100.0 463 100.0
Age categories
18-49 4,863 6.5% 1,216 4.8% 1,428 5.9% 2,219 8.7%
p<0.001
50-59 12,323 16.4% 3,643 14.2% 3,823 15.8% 4,857 19.1%
60-69 22,636 30.1% 7,403 28.9% 7,337 30.3% 7,896 31.0%
70-79 25,016 33.2% 9,201 36.0% 8,144 33.6% 7,671 30.1%
80+ 10,442 13.9% 4,113 16.1% 3,481 14.4% 2,848 11.2%
Gender
Male 46,447 61.7% 15,956 62.4% 14,881 61.5% 15,610 61.2%
p=0.018
Female 28,833 38.3% 962 37.6% 9,332 38.5% 9,881 38.8%
Hospitalization in the year prior to the index surgery
0 49,883 66.3% 17,685 69.1% 16,256 67.1% 15,942 62.5%
p<0.0011 17,308 23.0% 5,651 22.1% 5,480 22.6% 6,177 24.2%
>1 8,089 10.7% 224 8.8% 2,477 10.2% 3,372 13.2%
Abdominal surgery in the 3 years prior to the index surgery
No 70,685 93.9% 24,003 93.8% 22,714 93.8% 23,968 94.0%
p=0.560
Yes 4,595 6.1% 1573 6.2% 1499 6.2% 1,523 6.0%
Charlson score
0 60,011 79.7% 20,274 79.3% 19,210 79.3% 20,527 80.5%
p<0.0011 - 2 13,816 18.4% 4,822 18.9% 4,487 18.5% 4,507 17.7%
3+ 1,453 1.9% 480 1.9% 516 2.1% 457 1.8%
Year of index Hospitalization 
2002 - 2006 26,987 35.8% 10,127 39.6% 8,269 34.2% 8,591 33.7%
p<0.0012007 - 2010 24,491 32.5% 8,117 31.7% 7,706 31.8% 8,668 34.0%
2011 - 2014 23,802 31.6% 7,332 28.7% 8,238 34.0% 8,232 32.3%
Stoma creation during the index hospitalization
Yes 27,306 36.3% 8,481 33.2% 9,287 38.4% 9,538 37.4%
p<0.001
No 47,974 63.7% 17,095 66.8% 14,926 61.6% 15,953 62.6%
Surgical approach
Open 58,901 78.2% 21,118 82.6% 18,079 74.7% 1,9704 77.3%
p<0.001
Laparoscopy 16,379 21.8% 4,458 17.4% 6,134 25.3% 5,787 22.7%
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The main finding of the study was that the risk of a 
worse outcome was significantly higher among patients 
who underwent surgery in low-volume than in those 
who underwent surgery in high-volume hospitals. This 
association was independent from the other covariates and 
was found for all the outcomes.
A second finding, made possible by the longitudinal 
design of the study and already observed by others [11], 
was the shift over time of patients admitted to high-volume 
hospitals. As, throughout the study period, no specific 
laws, policy recommendations or guidelines were adopted 
to influence such a process, it suggests that a process of 
centralization is “spontaneously” underway.
Comparisons between studies on this topic are 
challenging and many factors should be taken in account 
to explain differences in findings. Differences in the 
inclusion/exclusion criteria, definition of perioperative 
mortality and HV, study design, data source, study period, 
specificity of different healthcare systems, and cultural and 
geographical aspects may largely explain discrepancies 
between study results. A specific consideration should be 
reserved to postoperative mortality, which is a rare event 
in rectal cancer. In their large population-based study, 
Bilimoria et al. [2] evaluated perioperative mortality in 
seven common malignancies. The rates of postoperative 
mortality for rectal cancer were the lowest among all other 
malignancies (1.9% in the highest and 3.0% in the lowest 
volume-hospitals, respectively). The corresponding figures 
for other malignancies were respectively: 5% and 5.9% 
(colon), 6.1% and 10.9% (esophagus), 6.2% and 11.9% 
(liver), 5.5% and 6.4% (lung), 4.9% and 10.5% (pancreas), 
and 5.7% and 8.9% (stomach). Based on these figures, 
the sample size powered to find statistically significant 
differences in postoperative mortality after rectal cancer 
surgery is crucial [12]. The overall rate of in-hospital 
mortality in our study was 1.3%, which is in the range 
(0.79% to 5.2%) of that reported by others [3, 13–15]; it 
was 0.9% and 1.6% in the highest and lowest HV tertile, 
respectively. With a such a small difference, only studies 
with a large sample size are able to capture a statistically 
significant difference. The only study to include more than 
50,000 cases showed results similar to ours [2]. The rates 
of in-hospital mortality decreased during the study period 
for each HV tertile; nevertheless, like others [2, 16–19], 
we found that the HV still remained an independent risk 
factor for in-hospital mortality. Opposite findings were 
reported by studies based on smaller sample sizes [4, 13–
15, 18, 20, 21].
Despite the exclusion of cancers located at the recto-
sigmoid junction, we found an APR rate of 16%, which 
is lower than that reported by most of the other studies 
[3, 14–16, 21, 22]. This is not surprising, because cultural 
aspects likely play a relevant role for this specific outcome, 
and may explain this discrepancy. Other explanations 
rely on the study period. Studies reporting on series of 
patients operated in the last century show rates of APR of 
more than 50% [21–23]. In addition, the rate of sphincter-
preserving procedures does not exactly reflect the rate 
of patients who are stoma-free. A proportion of patients, 
challenging to define, who underwent sphincter-preserving 
Table 2: Short-term outcomes by hospital volume
All patients  
Low 
volume
(1 - 12)
 
 
Medium 
volume
(13 - 31)
 
 
High 
volume
(32+)
 
 
n column % n column % n column % n column % p-value
No. of Patients 75,280 100.0 25,576 100.0 24,213 100.0 25,491 100.0
No. of hospitals/year 8280 100.0 6534 100.0 1283 100.0 463 100.0
Length of stay  
Lower median (1-12) 38,684 51.4% 10,865 42.5% 12,369 51.1% 15,450 60.6%
p<0.001
Upper median (13+) 36,596 48.6% 14,711 57.5% 11,844 48.9% 10,041 39.4%
Modality of discharge 
Alive 74,307 98.7% 25,166 98.4% 23,877 98.6% 25,264 99.1%
p<0.001
Dead 973 1.3% 410 1.6% 336 1.4% 227 0.9%
Abdominoperineal resection 
No 63,005 83.7% 20,624 80.6% 20,479 84.6% 21,902 85.9%
p<0.001
Yes 12,275 16.3% 4,952 19.4% 3,734 15.4% 3,589 14.1%
30-day readmission 
No 68,974 92.8% 23,334 92.7% 22,088 92.5% 23,552 93.2%
p<0.001
Yes 5,333 7.2% 1,832 7.3% 1,789 7.5% 1,712 6.8%
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surgery either had the stoma never closed or underwent a 
stoma creation as a consequence of an anastomotic leak. 
Compared to perioperative mortality, the association 
between HV and the rate of APR or permanent colostomy 
is less debated and the majority of authors report findings 
similar to ours [6, 9, 11, 15–20, 23–27], while only a few 
disagree [14, 28, 21].
We found a median LOS of 13 days which decreased 
overtime. While the LOS varies between studies due to 
differences in healthcare systems and cultural attitude [13, 
Table 3: Multivariate logistical regression analysis reporting the adjusted odds of each outcome
 In-hospital mortality  Abdominoperineal resection Length of stay 30-day readmission
Variables OR IC 95% OR IC 95% OR IC 95% OR IC 95% 
Volume (procedures/year)
High (32+) 1.00   1.00   1.00   1.00   
Medium (13 - 31) 1.41 1.17 1.70 1.16 1.07 1.26 1.54 1.37 1.74 1.09 1.00 1.18
Low (1 - 12) 1.49 1.25 1.78 1.49 1.38 1.61 2.29 2.05 2.55 1.10 1.02 1.19
Age categories (years) 
18-49 1.00 1.00 1.00 1.00
50-59 4.93 1.78 13.62 1.06 0.95 1.17 1.05 0.97 1.13 0.90 0.79 1.03
60-69 6.53 2.42 17.67 1.14 1.04 1.26 1.23 1.15 1.33 0.95 0.84 1.08
70-79 15.31 5.70 41.08 1.46 1.32 1.60 1.70 1.58 1.83 1.00 0.88 1.13
80+ 30.47 11.33 81.92 1.68 1.51 1.86 2.31 2.12 2.50 1.21 1.05 1.38
Gender 
Male 1.00 1.00 1.00 1.00
Female 0.66 0.57 0.76 1.01 0.97 1.06 0.89 0.86 0.92 0.79 0.75 0.84
Hospitalization in the year prior to the index surgery 
0 1.00 1.00 1.00 1.00
1 1.12 0.96 1.31 1.48 1.41 1.55 1.16 1.11 1.21 1.20 1.12 1.29
>1 1.39 1.15 1.69 2.00 1.87 2.13 1.32 1.25 1.40 1.27 1.16 1.40
Abdominal surgery in the 3 years prior to the index surgery 
No 1.00 1.00 1.00 1.00
Yes 1.47 1.20 1.80 0.87 0.80 0.95 1.02 0.95 1.10 1.10 0.98 1.23
Charlson score 
0 1.00 1.00 1.00 1.00
1 - 2 1.43 1.23 1.67 0.98 0.92 1.03 1.27 1.21 1.33 1.29 1.20 1.39
3+ 3.60 2.80 4.63 0.85 0.73 0.98 1.62 1.43 1.84 1.82 1.54 2.16
Year of index Hospitalization 
2002 - 2006 1.00 1.00 1.00 1.00
2007 - 2010 0.80 0.68 0.94 0.83 0.78 0.89 0.61 0.56 0.66 1.15 1.06 1.24
2011 - 2014 0.71 0.60 0.84 0.85 0.80 0.91 0.40 0.37 0.43 1.34 1.24 1.45
Stoma creation during the index hospitalization 
No 1.00   1.00   1.00   1.00   
Yes 1.04 0.91 1.19 0.72 0.69 0.76 1.53 1.47 1.58 1.62 1.53 1.72
Surgical approach 
Open 1.00 1.00 1.00 1.00
Laparoscopy 0.47 0.38 0.59 0.71 0.67 0.76 0.54 0.51 0.56 1.07 1.00 1.15
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15], a decreasing LOS over time is a largely observed 
phenomenon as a consequence of cost-containment 
policies and of the improvement of available home health 
care and skilled facilities. Interestingly, Balentine et al. 
[28] reported a greater likelihood of discharge to home 
for colorectal cancer patients admitted in high-volume vs. 
low-volume hospitals. There is large agreement on the 
favorable impact of HV on this outcome [6, 13, 15, 17].
Figure 2: Distribution of patients according to the hospitals’ annual volume of procedures, by period.
Figure 3: Temporal trends of the outcome measures according to the hospitals’ annual volume of procedures.
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The association of the 30-day readmission and HV 
is frequently reported for colorectal cancer, while few 
studies specifically report on this relationship after major 
elective rectal cancer surgery. Our finding of 7.2% of 30-
day readmission compares favorably with 10.7% reported 
by Doumouras e al. [29] Similar to Schneider et al. [30], 
we found that the risk of readmission increased across the 
study periods. In the multivariate analysis, being operated 
on in more recent time periods independently increased 
the odds of readmission. Some temporal factors might 
have had an impact on this finding. Neoadjuvant therapy 
has been increasingly used and is currently standard 
of care for mid-low locally advanced rectal cancer; 
however, it is also considered a potential risk factor of 
postoperative morbidity. In addition, the proportion of 
patients having a covering stoma during the study period 
increased from 31.5% in 2002-2006 to 41.8% in 2011-
2014. As postoperative morbidity and stoma-related 
problems have been found to impact negatively on 30-
day readmission [29, 30], it is reasonable to explain 
the increased rates of 30-day hospitalization with the 
increased use of neoadjuvant treatments and covering 
stoma. Furthermore, early discharge is thought to have an 
impact on readmissions; however, several studies found 
either no impact or an inverse association between LOS 
and the rate of 30-day readmission [29, 30].
The main strength of this study is the large sample 
size, the national-based source of data and the evaluation 
of multiple outcomes. The database does not contain 
any missing data which guarantees consistency of the 
analyses performed. Furthermore, the longitudinal design 
of the study produced a picture of variation over time of 
treatments and outcomes. Finally, unlike older studies, 
this analysis refers to a study period when neoadjuvant 
therapy, total mesorectal excision technique and the 
laparoscopic approach were widely diffused.
Limitations of the study are mainly related to the 
data source. Given its administrative nature, the data-base 
used does not allow for risk stratification. Clinical data 
such as tumor size, stage, tumor distance from the anal 
sphincter, or the use of adjuvant radiation or chemotherapy 
all of which may have an impact on short-term outcomes 
are not available. Likewise, the surgeon who performed 
the procedure is not identifiable and therefore the impact 
of surgeon volume on the outcomes is lacking. Although 
in some studies [21], the impact of surgeon volume on the 
outcomes has been found to be more relevant than HV, the 
latter appears to be an appropriate surrogate for surgeon 
volume in colorectal resections [31]. A further weakness 
is related to the lack of reliable data on postoperative 
complications. We excluded this outcome because it has 
been demonstrated that the information and coding on 
postoperative complications are often omitted or under-
reported. [32] Moreover, we could not report on long-term 
outcomes (i.e., overall and disease-free survival) because 
a link with databases with information on the vital status 
of patients was not feasible.
Finally, the translation of our findings in different 
healthcare systems should be verified but it is possible that 
proposed observations are generalizable to countries with 
a healthcare system similar to ours.
In conclusion, we report convincing evidence that 
hospital volume is independently associated with short-
term outcomes in the setting of the elective complex rectal 
cancer surgery. These findings do support the hypothesis 
that a process of centralization might improve outcomes. 
Such a process is spontaneously underway, without the aid 
of policy decisions or guideline recommendations.
MATERIALS AND METHODS
Study design and data source
This was a retrospective, longitudinal, national-
based cohort study. The data were retrieved from the 
administrative National Italian Hospital Discharge 
Dataset, which was established in 1996 and is currently 
utilized by the Italian Ministry of Health for administrative 
purposes (reimbursement of hospitals based on the 
Diagnosis-Related Group system). A national annual 
report on hospital admissions is available on-line for 
epidemiological studies; furthermore, the Ministry 
supplies researchers with anonymized data from the 
database [33]. Healthcare in Italy is universally delivered 
by public funds. The hospitals included in the national 
health system received the accreditation by the National 
Ministry of Health. This guarantees a standard in the 
medical treatment among them. The accreditation system 
has been adopted in Italy since 1992.
For the aims of this study, Ministry of Health 
provided data on admissions that took place from January 
1, 2000 to December 31, 2014.
The hospital discharge form reports on patient 
demographics, date of admission, surgical procedures and 
discharge. It codes for one primary and five secondary 
diagnoses and up to six performed procedures, surgical 
approach (open or laparoscopic), acuity of the admission 
(emergent, urgent or elective), and status at discharge 
(dead or alive). It does not report on stage of disease, 
distance of the tumor from the anal verge, preoperative 
or postoperative chemo and/or radiotherapy, and 
identification of the surgeon who performed the procedure. 
Moreover, information on overall and disease-free survival 
through linkage with other databases was not possible.
After approval of the study design by the Italian 
Ministry of Health, we had access to the data for this 
specific study. The analysis and interpretation of the data 
are the sole responsibility of the authors.
Patient selection and definitions
Patients were identified according to the 
International Classification of Diseases, Ninth Revision, 
Clinical Modification 2007 (ICD-9-CM). The inclusion 
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criteria were: age 18+ years, diagnosis of primary rectal 
cancer (ICD9-CM 154.x), major surgical procedure 
(ICD9-CM codes: 45.8, 45.95, 48.49, 48.5, 48.61-48.69) 
performed between January 2002 and November 2014. 
The available records regarding hospital admissions 
during 2000-2001 were used to exclude cases with a 
prevalent procedure for rectal cancer by January 1, 2002; 
the records regarding hospital admissions that took place 
in December 2014 were used to determine the 30-day 
readmission of patients with a hospital admission up to 
November 30, 2014.
The exclusion criteria were: prevalent procedure for 
rectal cancer before January 1, 2002, cancer of the anus 
(154.2-154.3) or of the recto-sigmoid junction (ICD9-CM 
154.1), minor rectal cancer procedures, placement of a 
stoma before the index hospitalization and discharge to 
acute-hospitals if the record of the second hospitalization 
was unavailable. Patients who died during the index 
hospitalization were excluded from the analysis of the 30-
day readmission.
Outcome measures
The outcome measures were: in-hospital mortality, 
which was defined as death due to any cause during 
the index hospitalization; rate of APR, which was the 
proportion of APR on the total major rectal procedures; 
LOS of the index hospitalization, which was defined 
as the difference between date of discharge and date of 
admission; and 30-day readmission, which was defined 
as any unplanned, distinct hospitalization within 30 days 
after the discharge of the index hospitalization.
These outcomes were chosen because they are 
widely used to measure the quality of healthcare and are 
easily retrieved from administrative databases; moreover, 
unlike other information such as postoperative morbidity, 
recording of these outcomes is mandatory and less 
frequently burdened by coding errors.
Hospital volume and additional covariates
Hospital volume was calculated as the average 
annual number of rectal cancer procedures performed 
at each hospital during the study period. We defined the 
thresholds of volume tertiles calculated on the whole study 
population and the hospitals were then categorized as low, 
medium and high volume for each study year accordingly.
The following additional covariates were 
assessed for the prediction of the outcomes of interest: 
age (subdivided into four classes: 18-59, 60-69, 70-
79, and 80+ years), gender (male, female), indexes of 
surgical complexity or comorbidity (non-colorectal 
surgery-related hospitalizations in the year prior to the 
index hospitalization, admissions for abdominal non-
colorectal cancer-related surgery and the Charlson 
Index both referring to the three years prior to the index 
hospitalization [34], year of the index hospitalization 
(subdivided into three classes: 2002-2006, 2007-
2010, 2011-2014), creation of stoma during the index 
hospitalization, and open or laparoscopic approach. Of 
course, 30-day readmission was calculated only on those 
patients who were alive at discharge.
Statistical analysis
The chi-square test was used to assess differences 
in demographics and clinical characteristics between 
hospitals with different levels of annual procedure 
volumes (low, medium and high).
Multivariate logistical regression was used to 
calculate the adjusted odds ratio (OR) for each of the four 
study outcomes (in-hospital mortality, APR, LOS, and 
30-day readmission). Multilevel regression was utilized 
to account for the hierarchical structure of the data (first 
level: patient; second level: hospital). In the multilevel 
analysis, the LOS was categorized into two levels, i.e., 
under and over the median.
Statistical significance was set at p<0.05. Stata 
software was used to perform all analyses (Stata 
Corporation, Stata Statistical Software: Release 13.0. 
College Station, TX).
Limitations and biases
The study is based on administrative data. Tumor 
size, stage, tumor distance from the anal sphincter, 
adjuvant radiation or chemotherapy, surgeon who 
performed the procedure, postoperative complications 
records are not present and analyzed. The database used 
has no link with other databases containing clinical 
information. The risk of biases is related to the absence of 
this information.
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